Hubbry Logo
Pasteur effectPasteur effectMain
Open search
Pasteur effect
Community hub
Pasteur effect
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Pasteur effect
Pasteur effect
Pasteur effect
View on Wikipedia
from Wikipedia

The Pasteur effect describes how available oxygen inhibits ethanol fermentation, driving yeast to switch toward aerobic respiration for increased generation of the energy carrier adenosine triphosphate (ATP).[1] More generally, in the medical literature, the Pasteur effect refers to how the presence of oxygen causes in a decrease in the cellular rate of glycolysis and suppression of lactate accumulation. The effect occurs in animal tissues, as well as in microorganisms belonging to the fungal kingdom.[2][3]

Discovery

[edit]

In 1857, microbiologist Louis Pasteur showed that aeration of yeasted broth causes cell growth to increase while the fermentation rate decreases, based on lowered ethanol production.[4][5]

Explanation

[edit]

Yeast fungi, being facultative anaerobes, can either produce energy through ethanol fermentation or aerobic respiration. When the O2 concentration is low, the two pyruvate molecules formed through glycolysis are each fermented into ethanol and carbon dioxide. While only 2 ATP are produced per glucose, this method is utilized under anaerobic conditions because it oxidizes the electron shuttle NADH into NAD+ for another round of glycolysis and ethanol fermentation.

If the concentration of oxygen increases, pyruvate is instead converted to acetyl CoA, used in the citric acid cycle, and undergoes oxidative phosphorylation. Per glucose, 10 NADH and 2 FADH2 are produced in cellular respiration for a significant amount of proton pumping to produce a proton gradient utilized by ATP Synthase. While the exact ATP output ranges based on considerations like the overall electrochemical gradient, aerobic respiration produces far more ATP than the anaerobic process of ethanol fermentation. The increased ATP and citrate from aerobic respiration allosterically inhibit the glycolysis enzyme phosphofructokinase 1 because less pyruvate is needed to produce the same amount of ATP.

Despite this energetic incentive, Rosario Lagunas has shown that yeast continue to partially ferment available glucose into ethanol for many reasons.[1] First, glucose metabolism is faster through ethanol fermentation because it involves fewer enzymes and limits all reactions to the cytoplasm. Second, ethanol has bactericidal activity by causing damage to the cell membrane and protein denaturing, allowing yeast fungus to outcompete environmental bacteria for resources.[6] Third, partial fermentation may be a defense mechanism against environmental competitors depleting all oxygen faster than the yeast's regulatory systems could fully switch from aerobic respiration to ethanol fermentation.

Practical implications

[edit]

The fermentation processes used in alcohol production is commonly maintained in low oxygen conditions, under a blanket of carbon dioxide, while growing yeast for biomass involves aerating the broth for maximized energy production. Despite the bactericidal effects of ethanol, acidifying effects of fermentation, and low oxygen conditions of industrial alcohol production, bacteria that undergo lactic acid fermentation can contaminate such facilities because lactic acid has a low pKa of 3.86 to avoid decoupling the pH membrane gradient that supports regulated transport.[7]

See also

[edit]

References

[edit]

Further reading

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Pasteur effect

View on Grokipedia
from Grokipedia
The Pasteur effect is a fundamental biochemical phenomenon in which the presence of oxygen inhibits the rate of and associated processes in facultative anaerobic organisms, such as , leading to reduced glucose consumption but more efficient ATP production through aerobic respiration. This effect was first observed by in 1861 while studying alcoholic in , where he noted that sugar utilization and production were markedly higher under anaerobic conditions than in the presence of air. At the molecular level, the Pasteur effect results from regulatory interactions between glycolytic and oxidative pathways, primarily involving competition for substrates like ADP and inorganic phosphate (Pi). Under aerobic conditions, oxidative phosphorylation rapidly regenerates ATP from ADP and Pi in mitochondria, elevating the ATP/ADP ratio and reducing their availability for glycolysis; this inhibits enzymes such as hexokinase and phosphofructokinase-1 (PFK-1) through allosteric feedback, with ATP and citrate acting as key inhibitors of PFK-1. Additionally, increased mitochondrial uptake of ADP under oxygen-rich conditions further limits glycolytic flux by altering phosphate compound balances. In broader physiological contexts, the Pasteur effect extends beyond microorganisms to mammalian tissues with high mitochondrial density, such as muscle and liver, where oxygen availability modulates glycolytic rates to optimize energy yield and prevent wasteful lactate accumulation. Under hypoxia, the reciprocal activation of glycolysis—mediated by transcription factors like hypoxia-inducible factor 1 (HIF-1)—restores glycolytic enzyme expression and activity, ensuring ATP maintenance despite limited oxygen. Dysregulation of this effect is implicated in pathologies, notably the Warburg effect in cancer cells, where aerobic glycolysis persists despite oxygen availability, supporting rapid proliferation through enhanced biosynthetic pathways.

Historical Background

Discovery by Louis Pasteur

In the mid-19th century, during the 1850s and 1860s, conducted foundational experiments on alcoholic fermentation as part of his extensive research into microbial processes and the . His work began with observations of activity in sugar-rich media, such as grape must and synthetic solutions, aiming to resolve debates between chemical and biological theories of fermentation. In a preliminary communication presented to the Scientific Society of on August 3, 1857, and published in the Comptes Rendus, Pasteur demonstrated that cells actively consume to build their own substance while producing alcohol and , establishing fermentation as a physiological act of living organisms rather than a mere . Pasteur's experiments involved controlled setups to compare anaerobic and aerobic conditions. He used sealed vessels, often filled with mercury to exclude air, containing precise mixtures of cane (typically 1.44 g), (about 9 g), and (0.3 g), incubated at 25–33°C for several days. Under anaerobic conditions, yeast fermented the efficiently, yielding high amounts of (around 7–8% by volume in some trials) and , but with modest cell proliferation—approximately 1 part yeast per 60–80 parts sugar consumed. When oxygen was introduced by agitating the mixture or using open vessels, yeast biomass increased dramatically, up to 1 part per 4–10 parts sugar, but production dropped sharply, with rates reduced by factors of 10 or more per unit of yeast. These quantitative differences were measured through of unfermented sugar residues and of alcohol yields. In his comprehensive 1860 memoir, Mémoire sur la fermentation alcoolique published in the Annales de Chimie et de Physique, Pasteur synthesized these findings, concluding that oxygen stimulates respiration and growth at the expense of . He observed that aerated yeast cells "grow vigorously... but [their] capacity to ferment tends to disappear," prioritizing cellular multiplication over alcohol synthesis. This led to his provocative assertion that oxygen suppresses fermentative activity, often paraphrased as "oxygen is the death of fermentation," underscoring the shift from anaerobic energy production to aerobic in yeast. These insights not only refuted prevailing chemical theories but also advanced understanding of microbial during Pasteur's era of fermentation studies.

Early Investigations and Naming

Following Louis Pasteur's foundational observation in 1857 that oxygen inhibits sugar in , subsequent investigations sought to dissect the phenomenon using cell-free systems. In 1897, Eduard Buchner demonstrated that cell-free extracts from could ferment glucose to alcohol and , proving that the process did not require intact living cells as Pasteur had believed. This breakthrough enabled controlled studies of independent of , laying groundwork for understanding oxygen's regulatory role without confounding vitalistic interpretations. Early 20th-century research advanced these insights through experiments on extracts. In 1906, Arthur Harden and William John Young showed that adding inorganic to yeast juice dramatically accelerated alcoholic , but the rate declined as was depleted, with the added incorporating into an organic ester later identified as hexosediphosphate. Their findings highlighted 's critical role in sustaining , providing an early mechanistic hint toward explaining why aerobic conditions might limit glycolytic flux by altering dynamics. The phenomenon gained formal recognition in the scientific literature during the 1920s amid broader efforts to map anaerobic and aerobic . In 1926, Otto Warburg coined the term "Pasteur effect" while investigating metabolic processes in tissues, describing it as the inhibition of sugar breakdown by oxygen. This naming encapsulated the effect's implications for metabolic efficiency. In the ensuing decade, Meyerhof and Gustav Embden further illuminated its ties to glycolytic pathways through experiments delineating intermediate steps, such as the conversion of to lactate under varying oxygen levels, solidifying the Pasteur effect's place in understanding respiration-fermentation balance.

Biochemical Mechanisms

Metabolic Pathways and Energy Yield

The Pasteur effect manifests through the distinct metabolic pathways available to facultative anaerobes, such as , which switch between anaerobic and aerobic respiration depending on oxygen availability. In the absence of oxygen, cells rely on followed by fermentation to generate energy rapidly, albeit with low efficiency. Glycolysis, the initial common step in both pathways, occurs in the cytosol and converts glucose to two molecules of pyruvate. The net reaction is: Glucose+2NAD++2ADP+2Pi→2pyruvate+2NADH+2H++2ATP+2H2O\text{Glucose} + 2\text{NAD}^+ + 2\text{ADP} + 2\text{P}_\text{i} \rightarrow 2\text{pyruvate} + 2\text{NADH} + 2\text{H}^+ + 2\text{ATP} + 2\text{H}_2\text{O} This process yields a net gain of 2 ATP molecules per glucose through substrate-level phosphorylation, with no further ATP production in the anaerobic route. In yeast under anaerobic conditions, pyruvate is then decarboxylated to acetaldehyde and reduced to ethanol, regenerating NAD⁺ to sustain glycolysis, while releasing CO₂ as a byproduct; this alcoholic fermentation step produces no additional ATP. Overall, anaerobic fermentation provides only 2 ATP per glucose but enables a higher rate of ATP production per unit time due to the rapid flux through the pathway. Under aerobic conditions, pyruvate enters the mitochondria, where it is oxidized to and enters the (TCA cycle), generating reducing equivalents (NADH and FADH₂) that drive in the . This complete oxidation of glucose to CO₂ and H₂O yields approximately 36-38 ATP per glucose molecule, including 2 from , 2 from the TCA cycle, and up to 34 from , making respiration far more efficient than . However, the respiration pathway operates at a slower rate under high glucose concentrations compared to the accelerated anaerobic flux, reflecting the Pasteur effect's emphasis on yield over speed. In facultative anaerobes like , this metabolic flexibility allows cells to prioritize for quick energy bursts in oxygen-limited environments or shift to respiration for maximal ATP extraction when oxygen is plentiful, optimizing survival across varying conditions.

Oxygen-Dependent Regulation

The presence of oxygen triggers a series of molecular regulatory mechanisms that inhibit while favoring , thereby conserving glucose and optimizing energy production in the Pasteur effect. Under aerobic conditions, the in mitochondria becomes active, leading to efficient ATP synthesis via . This elevates the ATP/ADP ratio and increases citrate levels from the tricarboxylic acid cycle, which exert feedback inhibition on key glycolytic enzymes. A primary site of regulation is phosphofructokinase-1 (PFK-1), the enzyme catalyzing the committed step of at fructose-6-phosphate to fructose-1,6-bisphosphate. High ATP levels allosterically bind to PFK-1, reducing its affinity for fructose-6-phosphate and slowing glycolytic flux. Similarly, citrate, accumulated under aerobic respiration, acts as an allosteric inhibitor of PFK-1, further dampening activity. This dual inhibition by ATP and citrate directly links respiratory efficiency to glycolytic control. , the final glycolytic enzyme converting phosphoenolpyruvate to pyruvate, is also subject to allosteric inhibition by elevated ATP, preventing unnecessary pyruvate production when mitochondrial respiration suffices. Inorganic phosphate (Pi) plays a crucial role in this oxygen-dependent modulation. Under anaerobic conditions, free Pi is abundant and activates PFK-1, supporting rapid . However, aerobic conditions enable , which rapidly recycles Pi into ATP, depleting cytosolic Pi levels and thereby limiting PFK-1 activity and overall glycolytic rate. Additionally, oxygen facilitates the mitochondrial , which oxidizes NADH generated during back to NAD⁺. This prevents NADH accumulation, which would otherwise inhibit glyceraldehyde-3-phosphate and force reliance on lactate . By maintaining NAD⁺ availability without lactate diversion, aerobic metabolism sustains balanced states and suppresses glycolytic overdrive.

Biological Significance

Effects in Microorganisms

In such as , the Pasteur effect manifests as a shift in upon exposure to oxygen, where is inhibited and cells redirect glucose toward aerobic respiration, favoring production over synthesis. This metabolic reprogramming allows yeast to achieve higher growth rates in nutrient-rich, aerobic environments by generating up to 18 ATP molecules per glucose via , compared to only 2 ATP from anaerobic glycolysis, thereby supporting increased and proliferation. Experimental studies have demonstrated that under anaerobic conditions, glucose consumption rates in S. cerevisiae can increase 5- to 10-fold relative to aerobic conditions, underscoring the inhibitory role of oxygen on glycolytic flux. Ecologically, the Pasteur effect provides S. cerevisiae with a competitive edge in microaerobic niches, such as fruit surfaces or fermenting environments, where limited oxygen prompts partial and accumulation acts as a against bacterial and fungal competitors. This strategy not only secures resources but also creates a selective habitat favoring -tolerant yeast strains. However, under high-glucose aerobic conditions, the related can override this, leading to production despite oxygen availability, contrasting the classical Pasteur inhibition. In bacteria, particularly facultative anaerobes like , the Pasteur effect similarly involves oxygen-mediated repression of fermentative pathways, shifting metabolism from mixed-acid or lactate fermentation to respiration for efficient energy yield. Aerobic conditions enhance ATP production, accelerating growth rates and in these organisms by minimizing wasteful byproduct formation, such as lactate or , which predominate anaerobically. This regulatory adaptation is briefly linked to oxygen-sensitive modulation of phosphofructokinase-1 (PFK-1) activity, serving as a key trigger for the metabolic switch.

Effects in Animal Cells and Tissues

In cells and tissues, the Pasteur effect describes the oxygen-mediated inhibition of , which shifts metabolism toward for greater ATP efficiency and reduces the accumulation of glycolytic end products like lactate. This phenomenon is prominent in tissues with abundant mitochondria, such as and hepatocytes, where normoxic conditions suppress glycolytic rates to maintain metabolic . In , oxygen availability during rest or moderate activity inhibits , nearly abolishing lactate production and thereby averting that could impair contractile function. In tissue, the effect similarly curbs excessive under normoxia, preserving neural energy balance and minimizing lactate buildup, which is critical for sustained cognitive activity. Under aerobic conditions, glycolysis rates in mammalian cells decrease by 70-90%, favoring the complete oxidation of glucose to yield approximately 30-36 ATP molecules per glucose molecule through the electron transport chain, compared to only 2 ATP from anaerobic glycolysis. In pathophysiological settings, such as ischemic tissues during stroke or myocardial infarction, hypoxia reverses the Pasteur effect by stabilizing hypoxia-inducible factor-1 (HIF-1), which upregulates glycolytic enzymes to accelerate ATP production via lactate fermentation, enabling short-term cell survival despite reduced oxygen. Contrastingly, in cancer cells, the Pasteur effect is inverted—termed the Warburg effect—where aerobic persists even in oxygenated environments, diverting glucose toward lactate production to fuel rapid proliferation and of macromolecules. Evolutionarily, the Pasteur effect in animal cells optimizes in oxygen-rich habitats by prioritizing oxidative , while retaining the capacity for glycolytic bursts during transient anaerobiosis, such as intense muscular exertion.

Applications and Implications

Industrial and Biotechnological Uses

In industrial ethanol production, such as and , anaerobic conditions are deliberately maintained to maximize yields by suppressing the Pasteur effect, which would otherwise redirect glucose toward aerobic respiration and favor over formation. This strategy ensures that a greater proportion of substrate carbon is converted to rather than , with typical processes limiting dissolved oxygen to below 0.1 mg/L to sustain high glycolytic flux. For instance, in large-scale bioethanol fermentations using Saccharomyces cerevisiae, oxygen exclusion prevents the 10- to 18-fold higher ATP yield from respiration, thereby prioritizing the inefficient but product-directed anaerobic pathway. Conversely, for production like (S. cerevisiae) used in food and feed applications, aerobic cultivation leverages the to achieve significantly higher cell yields, often 10- to 20-fold greater than under anaerobic conditions, due to the efficient energy generation from respiration supporting rapid proliferation. In fed-batch bioreactors, controlled at oxygen transfer rates of 100-200 mg O₂/L/h optimizes this shift, yielding concentrations exceeding 100 g/L dry weight while minimizing byproduct formation. Bioreactor strategies in industries like wine and production, dating back to the late , rely on precise control of dissolved oxygen levels to balance growth and product formation, exploiting the Pasteur effect to toggle between respiratory and fermentative modes. For example, initial aerobic phases promote propagation, followed by anaerobic shifts to drive accumulation, with sensors maintaining oxygen below 5% saturation during active to avoid yield losses. This metabolic shift to respiration under controlled forms the basis for yield optimization in such processes. In modern , post-2010 genetic modifications of strains, such as targeted overexpression of glycolytic enzymes like or deletion of respiratory regulators, aim to minimize the Pasteur effect, enabling continuous even in high-oxygen environments for enhanced productivity. These engineered S. cerevisiae variants support aerobic alcoholic in bioreactors, reducing oxygen dependency and improving scalability for applications like . A key challenge in these fermentations is contamination by (LAB), such as Lactobacillus species, which exploit the low (typically 3.5-4.5) generated from yeast-driven production to survive and compete, as the pKa of at 3.86 allows sufficient undissociated form for permeation without disrupting proton gradients. LAB ingress reduces yields by up to 20% through substrate competition and accumulation, necessitating monitoring and strategies in industrial setups.

Medical and Pathological Relevance

In conditions of ischemia and hypoxia, such as those occurring during or , the Pasteur effect is reversed, leading to a shift toward anaerobic glycolysis that elevates lactate production and contributes to and tissue damage. This metabolic adaptation, while initially compensatory, exacerbates cellular injury by promoting energy inefficiency and upon reperfusion. The Warburg effect in cancer cells, first described in the 1920s, represents a paradoxical aerobic that persists despite adequate oxygen availability, directly contrasting the Pasteur effect's typical inhibition of under aerobic conditions. This metabolic reprogramming supports rapid proliferation and biosynthetic demands in tumors, with key enzymes like phosphofructokinase-1 (PFK-1) often upregulated to sustain glycolytic flux. Recent research through 2025 has identified PFK-1 as a promising therapeutic target, with inhibitors showing potential to disrupt this aerobic and induce death without broadly affecting normal tissues. In and related metabolic disorders, dysregulation of the Pasteur effect in insulin-resistant tissues impairs the normal oxygen-mediated suppression of , resulting in inefficient energy utilization and elevated lactate levels that contribute to systemic complications. This altered metabolic coupling, often linked to excess fatty acid oxidation, hinders mitochondrial function and exacerbates in affected organs like muscle and liver. Therapeutic strategies leveraging the Pasteur effect include oxygen therapies, such as hyperbaric oxygen, which aim to reinstate aerobic in hypoxic tumor environments, thereby suppressing excessive and enhancing treatment efficacy. Additionally, pharmacological modulation of (AMPK) promotes metabolic flexibility, allowing cells to better toggle between glycolytic and oxidative pathways in pathological states like ischemia or cancer. Studies from the have revealed oxygen-dependent mitochondrial production as a mechanism that can induce a reverse Pasteur effect, stimulating even under aerobic conditions and challenging the traditional view of strict oxygen-mediated inhibition in certain mammalian cells. This formate-driven pathway highlights nuanced regulatory layers in metabolic adaptation, with implications for rethinking therapeutic interventions in hypoxia-related diseases.

References

  1. https://link.springer.com/article/10.1007/BF01874168
  2. https://www.nature.com/articles/2011126a0
  3. https://www.ncbi.nlm.nih.gov/books/NBK482303/
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC100265/
  5. https://www.nature.com/scitable/topicpage/yeast-fermentation-and-the-making-of-beer-14372813/
  6. https://onlinelibrary.wiley.com/doi/10.1002/1097-0061(20000615)16:8%3C755::AID-YEA587%3E3.0.CO;2-4
  7. https://www.nobelprize.org/prizes/chemistry/1907/buchner/lecture/
  8. https://pmc.ncbi.nlm.nih.gov/articles/PMC7756376/
  9. https://www.nobelprize.org/uploads/2018/06/harden-lecture.pdf
  10. https://onlinelibrary.wiley.com/doi/10.1002/yea.986
  11. https://escholarship.org/content/qt58p3d8sz/qt58p3d8sz.pdf
  12. https://www.jbc.org/article/S0021-9258%2820%2976366-0/fulltext
  13. https://www.nobelprize.org/prizes/uncategorized/otto-meyerhof-and-the-physiology-institute-the-birth-of-modern-biochemistry/
  14. https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/pasteur-effect
  15. https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2014.00017/full
  16. https://www.pnas.org/doi/10.1073/pnas.2409509121
  17. https://bio.libretexts.org/Bookshelves/Microbiology/Microbiology_%28Kaiser%29/Unit_7%253A_Microbial_Genetics_and_Microbial_Metabolism/18%253A_Microbial_Metabolism/18.3%253A_Aerobic_Respiration/18.3E%253A_Theoretical_ATP_Yield
  18. https://pubmed.ncbi.nlm.nih.gov/14317405/
  19. https://pmc.ncbi.nlm.nih.gov/articles/PMC8091952/
  20. https://www.sciencedirect.com/science/article/pii/B9781483231358500072
  21. https://www.sciencedirect.com/science/article/pii/B978012801238311342X
  22. https://pmc.ncbi.nlm.nih.gov/articles/PMC3150441/
  23. https://www.cell.com/trends/ecology-evolution/fulltext/S0169-5347(24)00240-4
  24. https://onlinelibrary.wiley.com/doi/10.1002/yea.1249
  25. https://www.researchgate.net/publication/8121340_Culture_of_Escherichia_coli_under_dissolved_oxygen_gradients_simulated_in_a_two-compartment_scale-down_system_Metabolic_response_and_production_of_recombinant_protein
  26. https://www.ncbi.nlm.nih.gov/books/NBK7919/
  27. https://pubmed.ncbi.nlm.nih.gov/4280359/
  28. https://www.sciencedirect.com/science/article/pii/B9780128035504000197
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC3710993/
  30. https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/pasteur-effect
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC3536072/
  32. https://journals.asm.org/doi/10.1128/mmbr.00025-07
  33. https://www.sciencedirect.com/science/article/pii/B9780081020654000110
  34. https://www.mdpi.com/2076-3417/14/20/9346
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC7711850/
  36. https://link.springer.com/article/10.1007/s00217-023-04251-8
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC2704822/
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC7074673/
  39. https://www.ncbi.nlm.nih.gov/books/NBK28046/
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC2743109/
  41. https://www.mdpi.com/2072-6694/12/10/2819
  42. https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-025-06897-2
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC10935242/
  44. https://www.sciencedirect.com/science/article/abs/pii/S0306987703000537
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC8473417/
  46. https://nutritionandmetabolism.biomedcentral.com/articles/10.1186/s12986-017-0178-2
  47. https://www.sciencedirect.com/science/article/pii/S0005272810007206
  48. https://www.researchgate.net/publication/340578727_Oxygen_dependent_mitochondrial_formate_production_and_the_reverse_Pasteur_effect
Add your contribution
Related Hubs
User Avatar
No comments yet.